Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Anteris Technologies Global Corp. ( (AVR) ) just unveiled an update.
On September 19, 2025, Anteris Technologies Global Corp. announced the adjournment of its Special Meeting of Stockholders due to a lack of quorum. The meeting, initially held virtually on September 18, 2025, was rescheduled to September 29, 2025, to allow more time for stockholders to vote on proposals. The company’s Board of Directors strongly recommends voting in favor of the proposals outlined in the Proxy Statement, which was filed with the SEC on August 18, 2025.
The most recent analyst rating on (AVR) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Anteris Technologies Global Corp. stock, see the AVR Stock Forecast page.
Spark’s Take on AVR Stock
According to Spark, TipRanks’ AI Analyst, AVR is a Neutral.
Anteris Technologies Global Corp. has a low overall stock score due to significant financial challenges, including declining revenues and persistent losses. The technical analysis indicates a bearish trend, and the valuation is unattractive with a negative P/E ratio. However, the recent ASX waiver for securities issuance is a positive corporate event, providing potential strategic opportunities.
To see Spark’s full report on AVR stock, click here.
More about Anteris Technologies Global Corp.
Anteris Technologies Global Corp. is a global structural heart company focused on designing, developing, and commercializing innovative medical devices to restore healthy heart function. The company, founded in Australia with a significant presence in Minneapolis, USA, is known for its lead product, the DurAVR® Transcatheter Heart Valve, which addresses aortic stenosis using its patented ADAPT® tissue technology.
Average Trading Volume: 190,258
Technical Sentiment Signal: Strong Buy
Current Market Cap: $202.3M
Learn more about AVR stock on TipRanks’ Stock Analysis page.